CEO and Co-Founder
Gene expression profiling
United States of America
Joel McComb co-founded BioSpyder Technologies in December 2011 and serves as the company’s CEO. Joel has more than 25 years of life science and business experience. Prior to BioSpyder, he served as the Senior Vice President and General Manager of Life Sciences at Illumina Inc., where he was responsible for managing all array and sequencing products and services related to the research market. Prior to joining Illumina, Joel held two high level positions at General Electric, Inc. He joined GE in 2004 as President, Healthcare Life Sciences-Discovery Systems. In 2007, he served as President of GE Healthcare, Interventional Medicine. Prior to this, he served as President of Life Sciences Discovery Systems (former Amersham Life Sciences). From 2001 to 2004, Joel served as the President and Chief Executive Officer of Innovadyne Technologies and was responsible for strategy and implementation of all its operations, beginning with its startup through its subsequent sale as a profitable business to Gilson, Inc. From 1995 to 2001, Joel held various positions with Beckman Coulter, including roles as the General Manager of Primary Care Diagnostic Division (the former SmithKline Diagnostics) and Director of Corporate Business Development. He has been a Director of Bio-Rad Laboratories, Inc. since July 2014. Joel earned a B.S. in Genetics from the University of California, Davis, and an MBA from the Golden Gate University in San Francisco.
High-throughput gene expression profiling, novel product for targeted sequencing, gene expression profiling tool, sample barcoding, simplified data analysis, expression profiling for any species